Literature DB >> 26722296

Extra-abdominal fibromatosis: Clinical and therapeutic considerations based on an illustrative case.

Rosario Fornaro1, Elisa Caratto1, Michela Caratto1, Alexander Salerno1, Francesca Sarocchi2, Giuseppe Minetti3, Marco Frascio1, Roberto Murialdo4, Mario Taviani1.   

Abstract

Extra-abdominal fibromatosis is a rare, benign disease that is characterized by a local but not metastatic invasivity. In particular, desmoid tumors of the chest wall represent only 10-20% of all deep fibromatoses. The disease occurs more often in females and has a higher incidence between puberty and the fourth decade of life. The present study reports the case of a 34-year-old female who came to our attention due to a voluminous mass in the right subcostal region. The magnetic resonance imaging of the upper abdomen confirmed the presence of a neoplasm localized between the anterior hepatic margin and the right costal plane. Through a right subcostal laparotomy, the voluminous 95×45×94-mm neoplasm was excised. Histological examination showed evidence consistent with extra-abdominal fibromatosis. The patient has not shown recurrence of the disease for 4 years since the surgery. Overall, radical surgery with disease-free resection margins is the prime treatment option for this disease. Other therapeutic options, such as radiotherapy, hormonal therapy or treatment with imatinib mesylate, can also be considered in certain cases.

Entities:  

Keywords:  chest wall; desmoid tumor; extra-abdominal fibromatosis; histology; surgery

Year:  2015        PMID: 26722296      PMCID: PMC4665811          DOI: 10.3892/ol.2015.3684

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  11 in total

Review 1.  A to Z of desmoid tumors.

Authors:  Atul B Shinagare; Nikhil H Ramaiya; Jyothi P Jagannathan; Katherine M Krajewski; Angela A Giardino; James E Butrynski; Chandrajit P Raut
Journal:  AJR Am J Roentgenol       Date:  2011-12       Impact factor: 3.959

2.  Desmoid tumour of the chest wall.

Authors:  J-L Lamboley; F Le Moigne; C Proust; F Thivolet-Bejui; F Tronc; D Revel; P Douek
Journal:  Diagn Interv Imaging       Date:  2012-06-19       Impact factor: 4.026

3.  Different biologic features of desmoid tumors in adult and juvenile patients: MR demonstration.

Authors:  J A Romero; E E Kim; C G Kim; W K Chung; I Isiklar
Journal:  J Comput Assist Tomogr       Date:  1995 Sep-Oct       Impact factor: 1.826

Review 4.  Update on desmoid tumors.

Authors:  C Escobar; R Munker; J O Thomas; B D Li; G V Burton
Journal:  Ann Oncol       Date:  2011-08-22       Impact factor: 32.976

Review 5.  Sporadic desmoid tumors of the chest: long-term follow-up of 28 multimodally treated patients.

Authors:  Zoltán Mátrai; László Tóth; Zoltán Szentirmay; Ferenc Rényi Vámos; Walter Klepetko; Pál Vadász; István Kenessey; Miklós Kásler
Journal:  Eur J Cardiothorac Surg       Date:  2011-03-23       Impact factor: 4.191

Review 6.  Multimodality management of desmoid tumors: how important is a negative surgical margin?

Authors:  Marcovalerio Melis; Jonathan S Zager; Vernon K Sondak
Journal:  J Surg Oncol       Date:  2008-12-15       Impact factor: 3.454

7.  Extra-abdominal desmoid tumors: a report of 234 cases.

Authors:  Henry J Mankin; Francis J Hornicek; Dempsey S Springfield
Journal:  J Surg Oncol       Date:  2010-10-01       Impact factor: 3.454

8.  The role of imatinib mesylate in adjuvant therapy of extra-abdominal desmoid tumors.

Authors:  Markos Ioannou; Nikolaos Demertzis; Ioanna Iakovidou; Stamatios Kottakis
Journal:  Anticancer Res       Date:  2007 Mar-Apr       Impact factor: 2.480

9.  Identification of biological factors predictive of response to imatinib mesylate in aggressive fibromatosis.

Authors:  A Dufresne; F Bertucci; N Penel; A Le Cesne; B Bui; M Tubiana-Hulin; I Ray-Coquard; D Cupissol; C Chevreau; D Perol; A Goncalves; M Jimenez; P P Bringuier; J Y Blay
Journal:  Br J Cancer       Date:  2010-07-27       Impact factor: 7.640

10.  Huge intrathoracic desmoid tumor.

Authors:  Majdi Ibrahim; Hasan Sandogji; Abdullah Allam
Journal:  Ann Thorac Med       Date:  2009-07       Impact factor: 2.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.